Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE: ADRCs in STEMI
NCT01216995Phase 2Completed
- Sponsor
- Plus Therapeutics
- Start
- Sep 2012
- Primary completion
- May 2014
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of Cytori Cell Therapy in ST elevation myocardial infarction (STEMI), sponsored by Plus Therapeutics. Started Sep 2012; status: completed.
02
Drugs
Cytori Cell Therapy
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01216995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216995.